Resonance Health Limited announced earnings results for the full year ended June 30, 2021. For the full year, the company announced sales was AUD 3.778 million compared to AUD 3.668 million a year ago. Net income was AUD 585,858 compared to net loss of AUD 715,076 a year ago. Basic earnings per share from continuing operations was 0.13 cents compared to basic loss per share from continuing operations of 0.17 cents a year ago.